Atlas Trials

Eculizumab in Primary MPGN

Clinical trial NCT02093533 · COMPLETED

Trial details

NCT number
NCT02093533
Sponsor
Mario Negri Institute for Pharmacological Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Membranoproliferative Glomerulonephritis
Start date
2014-03-01
Primary completion
2017-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.